Qual é o preço para DelMar Pharmaceuticals, Inc. (DMPWW)

O preço para DelMar Pharmaceuticals, Inc. (DMPWW) é $0.005

Qual é a capitalização de mercado para DelMar Pharmaceuticals, Inc. (DMPWW)

A capitalização de mercado para DelMar Pharmaceuticals, Inc. (DMPWW) é $1.74K

DelMar Pharmaceuticals, Inc. (DMPWW) Margem Operacional

Kintara Therapeutics, Inc., previously known as DelMar Pharmaceuticals, Inc. until its rebranding in August 2020, operates as a clinical-stage pharmaceutical firm. Headquartered in San Diego, California, and established in 2009, the company is committed to advancing and bringing to market anti-cancer treatments for patients. Its development pipeline includes two advanced therapeutic candidates. One is VAL-083, a DNA-targeting agent poised for Phase III trials, designed to combat various drug-resistant solid tumors such as glioblastoma multiforme, ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma. The other is REM-001, a late-stage photodynamic therapy intended for conditions like cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and addressing access graft failure in hemodialysis patients. Kintara Therapeutics also maintains a strategic alliance with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. for the manufacturing and commercialization of VAL-083 within the Chinese market.

Ano	Margem Operacional	Alterar
Não há dados suficientes para as datas fornecidas.

Ano

Margem Operacional

Alterar

Não há dados suficientes para as datas fornecidas.

Empresa	Margem Operacional	Diferença na Margem Operacional	País
Vertex Pharmaceuticals Incorporated VRTX.US	38.97%	-	US
Argenx SE ARGX.US	28.81%	-	NL
Lonza Group AG LONN.SW	0.00%	-	CH
UCB S.A. UCB.BR	31.23%	-	BE
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	-	KR

Empresa

Margem Operacional

Diferença na Margem Operacional

País